Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned
- PMID: 34263023
- PMCID: PMC8252337
- DOI: 10.1177/23742895211020487
Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned
Abstract
The rapidly spreading COVID-19 pandemic demanded immediate organizational pivots in departments of laboratory medicine and pathology, including development and implementation of severe acute respiratory syndrome coronavirus 2 diagnostics in the face of unprecedented supply chain shortages. Laboratory medicine and pathology educational programs were affected in numerous ways. Here, we overview the effects of COVID-19 on the large, academic Department of Laboratory Medicine and Pathology educational practice at Mayo Clinic, highlighting lessons learned for the post-pandemic era and planning for the possibility of a future pandemic.
Keywords: COVID-19; education; laboratory medicine; pathology; virtual.
© The Author(s) 2021.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Patel reports grants from Merck, ContraFect, TenNor Therapeutics Limited and Shionogi. Dr Patel is a consultant to Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST, and Qvella; monies are paid to Mayo Clinic. Dr Patel is also a consultant to Netflix. In addition, Dr Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. Dr Patel receives an editor’s stipend from IDSA and honoraria from the NBME, Up-to-Date and the Infectious Diseases Board Review Course.
Figures

References
LinkOut - more resources
Full Text Sources